<it>pncA</it> mutations in clinical <it>Mycobacterium tuberculosis</it> isolates from Korea
<p>Abstract</p> <p>Background</p> <p>Pyrazinamide (PZA) is among the first-line drugs for the treatment of tuberculosis. In vitro, it kills semidormant mycobacteria only at low pH. The purpose of this study was to compare PZA resistance with pyrazinamidase (PZase) activ...
Main Authors: | Kim Cheol Min, Son Han Chul, Lee Min Ki, Chang Chulhun Ludgerus, Lee Jung Yoo, Park Soon Kew, Jang Hyun Jung, Park Hee Kyung, Jeong Seok Hoon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-06-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/1/4 |
Similar Items
-
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
by: Shi D, et al.
Published: (2022-08-01) -
Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01) -
Characteristics of <it>pncA </it>mutations in multidrug-resistant tuberculosis in Taiwan
by: Lee Yu-Chin, et al.
Published: (2011-09-01) -
Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>
by: Wang Nan,, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Published: (2023-12-01) -
INSERSI GEN pncA KE DALAM PLASMID pGEM-T
by: Eli Hendrik Sanjaya
Published: (2016-12-01)